Atlas Trials

USWM CT, LLC

9 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch USWM CT, LLC

RecordFirmDate
SPEARHEAD-3 Pediatric Study (NCT05642455)USWM CT, LLC2023-09-01
ADP-A2M4CD8 Monotherapy and in Combination With Nivolumab in HLA-A2+ Subjects With MAGE-A4 Positive Ovarian Cancer (SURPASS-3) (NCT05601752)USWM CT, LLC2023-06-26
Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors (NCT03967223)USWM CT, LLC2019-12-31
Study to Evaluate Safety and Antitumor Activity of Lete-Cel (GSK3377794) in HLA-A2+ Participants With NY-ESO-1 Positive Previously Treated Advanced (Metastatic or Unresectable) Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT06703346)USWM CT, LLC2019-12-31
ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) (NCT04044859)USWM CT, LLC2019-08-20
Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell Liposarcoma (NCT04044768)USWM CT, LLC2019-08-13
Adoptive Cell Therapy Long-term Follow-up (LTFU) Study (NCT03391778)USWM CT, LLC2018-04-09

Track USWM CT, LLC automatically

Every clearance here is in the API, with alerts when new ones post.